Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICUCW) Common Equity (2023 - 2025)

SeaStar Medical Holding's Common Equity history spans 3 years, with the latest figure at $10.4 million for Q4 2025.

  • For Q4 2025, Common Equity rose 577.14% year-over-year to $10.4 million; the TTM value through Dec 2025 reached $10.4 million, up 577.14%, while the annual FY2025 figure was $10.4 million, 577.14% up from the prior year.
  • Common Equity reached $10.4 million in Q4 2025 per ICUCW's latest filing, down from $11.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $11.5 million in Q3 2025 to a low of -$23.4 million in Q1 2023.
  • Average Common Equity over 3 years is -$4.4 million, with a median of -$3.3 million recorded in 2024.
  • Peak YoY movement for Common Equity: soared 41.3% in 2024, then soared 558774.46% in 2025.
  • A 3-year view of Common Equity shows it stood at -$13.9 million in 2023, then skyrocketed by 84.26% to -$2.2 million in 2024, then surged by 577.14% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Common Equity are $10.4 million (Q4 2025), $11.5 million (Q3 2025), and $3.3 million (Q2 2025).